blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News flashes

New version of the European Patent Register - SPC information for Unitary Patents.

2024-03-06

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP2969006

EP2969006 - COMPOSITIONS AND METHODS FOR TREATING AN IMMUNODEFICIENCY VIRUS INFECTION [Right-click to bookmark this link]
StatusThe application is deemed to be withdrawn
Status updated on  15.03.2019
Database last updated on 06.07.2024
FormerExamination is in progress
Status updated on  27.04.2018
FormerRequest for examination was made
Status updated on  20.06.2017
Most recent event   Tooltip15.03.2019Application deemed to be withdrawnpublished on 17.04.2019  [2019/16]
Applicant(s)For all designated states
The J. David Gladstone Institutes
1650 Owens Street
San Francisco, CA 94158 / US
[2016/03]
Inventor(s)01 / WEINBERGER, Leor S.
945 Sunnyhills Road
Oakland, CA 94610 / US
02 / NOTTON, Timothy J.
1844 Fell Street
San Francisco, California 94117 / US
 [2016/03]
Representative(s)Mewburn Ellis LLP
Aurora Building
Counterslip
Bristol BS1 6BX / GB
[N/P]
Former [2016/03]Brasnett, Adrian Hugh, et al
Mewburn Ellis LLP
City Tower
40 Basinghall Street
London EC2V 5DE / GB
Application number, filing date14770952.113.03.2014
[2016/03]
WO2014US26423
Priority number, dateUS201361784844P14.03.2013         Original published format: US 201361784844 P
[2016/03]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2014151771
Date:25.09.2014
Language:EN
[2014/39]
Type: A1 Application with search report 
No.:EP2969006
Date:20.01.2016
Language:EN
The application published by WIPO in one of the EPO official languages on 25.09.2014 takes the place of the publication of the European patent application.
[2016/03]
Search report(s)International search report - published on:US25.09.2014
(Supplementary) European search report - dispatched on:EP06.10.2016
ClassificationIPC:A61P31/18, C12N15/113
[2016/03]
CPC:
A61K35/76 (EP,US); A61K38/162 (EP,US); A61K39/12 (EP,US);
A61K39/21 (EP,US); A61P31/18 (EP); C12N7/00 (US);
C12N2740/16021 (EP,US); C12N2740/16032 (EP,US); C12N2740/16033 (US);
C12N2740/16062 (US) (-)
C-Set:
A61K35/76, A61K2300/00 (EP,US);
A61K38/162, A61K2300/00 (US,EP)
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2016/03]
TitleGerman:ZUSAMMENSETZUNGEN UND VERFAHREN ZUR BEHANDLUNG EINER IMMUNSCHWÄCHEVIRUSINFEKTION[2016/03]
English:COMPOSITIONS AND METHODS FOR TREATING AN IMMUNODEFICIENCY VIRUS INFECTION[2016/03]
French:COMPOSITIONS ET PROCÉDÉS POUR TRAITER UNE INFECTION PAR UN VIRUS D'IMMUNODÉFICIENCE[2016/03]
Entry into regional phase21.08.2015National basic fee paid 
21.08.2015Search fee paid 
21.08.2015Designation fee(s) paid 
21.08.2015Examination fee paid 
Examination procedure21.08.2015Examination requested  [2016/03]
25.08.2017Amendment by applicant (claims and/or description)
02.05.2018Despatch of a communication from the examining division (Time limit: M06)
13.11.2018Application deemed to be withdrawn, date of legal effect  [2019/16]
10.12.2018Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time  [2019/16]
Divisional application(s)The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is  02.05.2018
Request for further processing for:The application is deemed to be withdrawn due to failure to reply to the Extended European Search Report/Written Opinion of the International Searching Authority/International Preliminary Examination Report/Supplementary international search report/Supplementary European search report
25.08.2017Request for further processing filed
25.08.2017Full payment received (date of receipt of payment)
Request granted
04.09.2017Decision despatched
Fees paidRenewal fee
31.03.2016Renewal fee patent year 03
27.03.2017Renewal fee patent year 04
27.03.2018Renewal fee patent year 05
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:Search[XI]  - MARIO R. MAUTINO ET AL, "Modified Human Immunodeficiency Virus-Based Lentiviral Vectors Display Decreased Sensitivity to Trans -Dominant Rev", HUMAN GENE THERAPY, US, (20000410), vol. 11, no. 6, doi:10.1089/10430340050015509, ISSN 1043-0342, pages 895 - 908, XP055305178 [X] 1-6,8-14 * abstract * * page 895 - page 900 * [I] 15

DOI:   http://dx.doi.org/10.1089/10430340050015509
 [XI]  - E. OLIVETTA ET AL, "cis Expression of the F12 Human Immunodeficiency Virus (HIV) Nef Allele Transforms the Highly Productive NL4-3 HIV Type 1 to a Replication-Defective Strain: Involvement of both Env gp41 and CD4 Intracytoplasmic Tails", JOURNAL OF VIROLOGY., US, (20000101), vol. 74, no. 1, doi:10.1128/JVI.74.1.483-492.2000, ISSN 0022-538X, pages 483 - 492, XP055305176 [X] 1-4,7-9,11-14 * abstract * * page 483 - page 484 * * page 487 - page 491 * [I] 15

DOI:   http://dx.doi.org/10.1128/JVI.74.1.483-492.2000
International search[Y]US6248721  (CHANG LUNG-JI [US]);
 [Y]US2003064071  (LITTMAN DAN R [US], et al);
 [Y]US2010015087  (ENSOLI BARBARA [IT]);
 [Y]WO2011146612  (UAB RESEARCH FOUNDATION [US], et al);
 [Y]WO2012019991  (INST NAT SANTE RECH MED [FR], et al);
 [X]  - ROUZINE, I. ET AL., "Design Requirements For Interfering Particles To Maintain Coadaptive Stability With HIV-1.", J. VIROL., (20121205), vol. 87, no. 4;, pages 2081 ; PAGES 2081 - 2093, XP055283053

DOI:   http://dx.doi.org/10.1128/JVI.02741-12
 [Y]  - D'COSTA, J ET AL., "Human Immunodeficiency Virus Type 2 Lentiviral Vectors: Packaging Signal And Splice Donor In Expression And Encapsidation.", JOUMAL OF GENERAL VIROLOGY., (2001), vol. 82, pages 425 - 434, XP002969190
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.